Clinical trial
A Study of the Safety and Effectiveness of Galantamine Versus Placebo in the…
NCT00261573 · Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Industry · Completed
Key facts
| NCT number | NCT00261573 |
|---|---|
| Title | A Study of the Safety and Effectiveness of Galantamine Versus Placebo in the Treatment of Patients With Vascular Dementia or Mixed Dementia |
| Official title | The Safety and Efficacy of Galantamine in the Treatment of Vascular and Mixed Dementia |
| Lead sponsor | Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Alzheimer Disease, Vascular Dementia |
| Intervention type | Drug |
| Interventions | galantamine hydrobromide |
| Enrollment | 593 |
| Start date | Dec 1, 1998 |
| Completion | Dec 1, 2000 |
| First posted | Dec 5, 2005 |
| Last update posted | May 18, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: